Sutro Biopharma, Inc. (STRO)
24.45
-0.09
(-0.37%)
USD |
NASDAQ |
Mar 12, 16:00
23.01
-1.44
(-5.89%)
Pre-Market: 08:26
Sutro Biopharma Shareholders Equity (Quarterly) : -87.27M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| GT Biopharma, Inc. | 5.787M |
| Rhythm Pharmaceuticals, Inc. | 139.07M |
| Crinetics Pharmaceuticals, Inc. | 992.08M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 209.66M |
| Total Liabilities (Quarterly) | 296.93M |
| Debt to Equity Ratio | -2.607 |
| Current Ratio | 2.533 |
| Net Debt Paydown Yield | -10.04% |